These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15141525)

  • 1. [Antifungal immunity and its mechanism in female genitalia].
    Spacek J; Jílek P; Buchta V; Drahosová M; Förstl M; Kalousek I
    Ceska Gynekol; 2004 Mar; 69(2):133-40. PubMed ID: 15141525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic immunity in patients with recurrent vulvovaginal candidiasis].
    Jílek P; Spacek J; Buchta V; Kucera Z; Drahosová M; Förstl M; Andrýs C
    Ceska Gynekol; 2005 Nov; 70(6):453-9. PubMed ID: 17955799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recurrent vulvovaginal candidiasis--possibility of its treatment].
    Spacek J; Buchta V; Jílek P; Krejsek J; Pidrman V; Kalousek I; Matula V; Kestránek J; Drahosová M; Vejsová M; Forstl M
    Ceska Gynekol; 2008 Jun; 73(3):179-84. PubMed ID: 18646671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Microbiological findings in patients with recurrent vulvovaginal candidiasis in the Hradec Králové Faculty Hospital 1995-2002].
    Buchta V; Spacek J
    Ceska Gynekol; 2004 Jan; 69(1):7-14. PubMed ID: 15112380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vulvodynia and the possibility of its management].
    Kestránek J; Matula V; Pidrman V; Taláb R; Jílek P; Buchta V; Spacek J
    Ceska Gynekol; 2010 Dec; 75(6):521-6. PubMed ID: 27534008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is diabetes mellitus a risk factor in genital yeast infections?].
    Buchta V; Matula V; Kestřánek J; Vejsová M; Křivčíková L; Spaček J
    Ceska Gynekol; 2013 Dec; 78(6):537-44. PubMed ID: 24372432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Host-yeast interactions in relation to the urogenital tract, vulvovaginal candidiasis and urologic aspects of mycotic diseases].
    Spacek J; Buchta V; Veselský Z; Kalousek I
    Ceska Gynekol; 2003 Nov; 68(6):432-9. PubMed ID: 15042854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors of mesenchymal and mixed tumors of uterus].
    Spacek J; Laco J; Petera J; Jílek P; Krepinská E; Rezác A; Stipl S
    Ceska Gynekol; 2009 Aug; 74(4):292-7. PubMed ID: 20564985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal candidiasis: review and role of local mucosal immunity.
    Fidel PL
    AIDS Patient Care STDS; 1998 May; 12(5):359-66. PubMed ID: 11361971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathogenesis of recurrent vulvovaginal candidiasis.
    Fidel PL; Sobel JD
    Clin Microbiol Rev; 1996 Jul; 9(3):335-48. PubMed ID: 8809464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What is the current stage of vulvovaginal discomfort diagnostics in the Czech Republic? Pilot analysis].
    Kestřánek J; Jílek P; Matula V; Buchta V; Gregor M; Spaček J
    Ceska Gynekol; 2013 Dec; 78(6):522-7. PubMed ID: 24372429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospective study the prevalence of different candida strains and their sensitivity to different antimycotic treatment in women with vulvovaginal candidiasis].
    Vráblik J; Masata J; Jedlicková A; Hájícková M
    Ceska Gynekol; 2007 Jan; 72(1):27-32. PubMed ID: 17357346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histopathologic prognostic factors, serum markers and selected molecular biologic factors in ovarian carcinoma].
    Spacek J; Jílek P; Petera J; Tesarík Z
    Ceska Gynekol; 2002 Nov; 67(6):343-9. PubMed ID: 12661373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
    Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
    Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current possibilities for diagnosis of vulvovaginal infection].
    Masata J; Jedlicková A; Poislová M; Masatová D; Martan A
    Ceska Gynekol; 2010 Apr; 75(2):111-7. PubMed ID: 20518264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity in vaginal candidiasis.
    Fidel PL
    Curr Opin Infect Dis; 2005 Apr; 18(2):107-11. PubMed ID: 15735412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vulvovaginal candidiasis: An old disease with new challenges].
    Miró MS; Rodríguez E; Vigezzi C; Icely PA; Gonzaga de Freitas Araújo M; Riera FO; Vargas L; Abiega C; Caeiro JP; Sotomayor CE
    Rev Iberoam Micol; 2017; 34(2):65-71. PubMed ID: 28431891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local immune responsiveness following intravaginal challenge with Candida antigen in adult women at different stages of the menstrual cycle.
    Fidel PL; Barousse M; Lounev V; Espinosa T; Chesson RR; Dunlap K
    Med Mycol; 2003 Apr; 41(2):97-109. PubMed ID: 12964841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct protective host defenses against oral and vaginal candidiasis.
    Fidel PL
    Med Mycol; 2002 Aug; 40(4):359-75. PubMed ID: 12230215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent vulvovaginal candidiasis: why does it occur?
    Rodgers CA; Beardall AJ
    Int J STD AIDS; 1999 Jul; 10(7):435-9; quiz 440-1. PubMed ID: 10454177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.